Physician profile
Joy D Cox
NPI 1174643357
$4,656.38
in general payments reported to CMS, 2019-2025
24 companies · $543 in 2025
The $543 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $128 · 2021: $612 · 2022: $1,397 · 2023: $1,166 · 2024: $589 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,118 · Education: $99.99 · Travel and Lodging: $57.00 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,117.78 |
| Education | $99.99 |
| Travel and Lodging | $57.00 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,638.54 | 2019-2025 | Upsylon, Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous), Solyx Sis System |
| Intuitive Surgical, INC. | $682.81 | 2023 | Da Vinci Surgical System |
| Astellas Pharma US INC | $476.34 | 2019-2024 | Myrbetriq, Veozah |
| Coloplast Corp | $246.68 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $235.44 | 2024-2025 | Gemtesa, Myfembree |
| Caldera Medical, INC | $234.79 | 2021-2023 | Desara |
| Axonics, INC. | $194.33 | 2021-2024 | Axonics |
| Abbvie INC. | $170.07 | 2019-2023 | Lo Loestrin Fe |
| Aspira Women'S Health INC | $160.04 | 2022-2024 | Ova1 |
| Channel Medsystems, INC. | $146.28 | 2023 | |
| Hologic Sales and Service, LLC | $130.19 | 2021-2024 | Acessa Provu System, Myosure Tissue Removal Device |
| Coopersurgical, INC. | $92.18 | 2019-2024 | Endosee |
| Bayer Healthcare Pharmaceuticals INC. | $37.67 | 2021-2022 | |
| Medtronic, INC. | $32.97 | 2021-2023 | Truclear |
| Exeltis, USA INC. | $32.52 | 2021-2023 | Slynd |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $28.31 | 2021 | |
| Therapeuticsmd, INC. | $19.89 | 2022 | |
| Mayne Pharma Commercial LLC | $19.65 | 2022 | |
| Merck Sharp & Dohme LLC | $15.97 | 2021 | |
| Novo Nordisk INC | $12.86 | 2023 | Wegovy |
| Organon LLC | $12.53 | 2023 | Nexplanon |
| Covidien LP | $12.32 | 2019 | |
| Agile Therapeutics, INC. | $12.12 | 2021 | |
| Olympus America INC. | $11.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.